Der kommer mere fart i de europæiske vaccinationer, mener Nordea, fordi flere europæiske lande nu har godkendt AstraZeneca-vaccinen for mennesker over 65 år. Desuden forsøger Rusland at producere sin Sputnik-vaccine i Italien og måske andre EU-lande.
European countries are warming up to AstraZeneca
Contrary to initial reluctance, European countries are now moving to vaccinate older people with AstraZeneca’s vaccine as data proves good results in other countries’ vaccination programmes.
European countries are changing guidance on AstraZeneca and allowing it to be used on people older 65. Contrary to many European countries initial reluctance to use the AstraZeneca vaccine on elderly people, both Germany, France and Denmark have recently changed its recommendation on the vaccine to encompass the elderly as well.
The Russian vaccine, Sputnik, may be produced on european soil in the summer. The vaccine is still under review for approval at the EMA and currently, the EU holds no agreements of deliveries of Sputnik. However, if approved and production scales up in the EU, the russian vaccine may become a viable option for roll-out in the EU, although geopolitical tensions may curb this development.
